In addition, Orai1 was consistently expressed in CD4 T cells after recovery from AKI and the use of the SOCE pathway inhibitor (YM58483/BPT2) significantly attenuated ischemia-reperfusion kidney injury, which was associated with reduced Th17 cells. The gene discussed is ORAI1; the disease is acute kidney injury.